Skip to main content
. Author manuscript; available in PMC: 2014 Apr 8.
Published in final edited form as: J Neurosurg Spine. 2012 Jan;16(1):93–101. doi: 10.3171/2011.9.SPINE11435

Table 2. Scores on the BBB scale in the efficacy study.

Experimental Groups Mean BBB Score ± SEM on Day 13 Comparison p Values

Controls ReGel 1.5 mg/ml 3.0 mg/ml
treatment on Day 0*
 9L tumor Day 0 (control) 5.38 ± 3.54 NA 0.621 0.007 0.004
 9L tumor & ReGel (vehicle only) Day 0 7 ± 2.46 0.621 NA 0.003 0.005
 9L tumor & 1.5 mg/ml OncoGel Day 0 15.25 ± 1.19 0.007 0.003 NA 0.554
 9L tumor & 3.0 mg/ml OncoGel Day 0 14.5 ± 0.33 0.004 0.005 0.554 NA
treatment on Day 5
 9L tumor Day 0 (control) 3.2 ± 1.08 NA 0.162 0.013 0.016
 9L tumor Day 0 & ReGel (vehicle only) Day 5 5.87 ± 1.35 0.162 NA 0.108 0.29
 9L tumor Day 0 & 1.5 mg/ml OncoGel Day 5 9.25 ± 1.42 0.013 0.108 NA 0.266
 9L tumor Day 0 & 3.0 mg/ml OncoGel Day 5 7.5 ± 0.5 0.016 0.29 0.266 NA
*

Eight rats in each group (32 total).

Five rats in the control group, 8 rats in each of the other 3 groups (29 total).